Search research articles
Contact Us
Filters
Showing results (1-10 of 162) with videos related to
Page
of 17
Sort By:
Journal of the American College of Cardiology
|
July 11, 2002
Coronary plaque regression: role of low density lipoprotein-apheresis
Philip J Barter
Clinical Chemistry
|
August 27, 2010
The relationship between cholesteryl ester transfer protein and cardiovascular risk
Philip J Barter
Endocrinology and Metabolism (Seoul, Korea)
|
January 8, 2014
High density lipoprotein: a therapeutic target in type 2 diabetes
Philip J Barter
Diabetes & Metabolism Journal
|
July 9, 2011
The causes and consequences of low levels of high density lipoproteins in patients with diabetes
Philip J Barter
Circulation
|
May 9, 2018
High- Versus Low-Dose Statin: Effects on Cardiovascular Events and All-Cause Death
Philip J Barter
Journal of Lipid Research
|
May 3, 2012
Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk
Philip J Barter, Kerry-Anne Rye
Circulation Research
|
September 16, 2006
Homocysteine and cardiovascular disease: is HDL the link?
Philip J Barter, Kerry-Anne Rye
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 24, 2008
Antiinflammatory actions of HDL: a new insight
Kerry-Anne Rye, Philip J Barter
The Journal of Clinical Endocrinology and Metabolism
|
May 17, 2019
HDL Cholesterol Level and Mortality Occurrence in the Elderly: Is the Good Cholesterol Always Good?
Raul D Santos, Philip J Barter
Circulation Research
|
January 4, 2014
Regulation of high-density lipoprotein metabolism
Kerry-Anne Rye, Philip J Barter
Page
of 17
Search research articles
Search
Showing results (1-10 of 162) with videos related to
Sort By:
Page
of 17
Journal of the American College of Cardiology
|
July 11, 2002
Coronary plaque regression: role of low density lipoprotein-apheresis
Philip J Barter
Clinical Chemistry
|
August 27, 2010
The relationship between cholesteryl ester transfer protein and cardiovascular risk
Philip J Barter
Endocrinology and Metabolism (Seoul, Korea)
|
January 8, 2014
High density lipoprotein: a therapeutic target in type 2 diabetes
Philip J Barter
Diabetes & Metabolism Journal
|
July 9, 2011
The causes and consequences of low levels of high density lipoproteins in patients with diabetes
Philip J Barter
Circulation
|
May 9, 2018
High- Versus Low-Dose Statin: Effects on Cardiovascular Events and All-Cause Death
Philip J Barter
Journal of Lipid Research
|
May 3, 2012
Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk
Philip J Barter, Kerry-Anne Rye
Circulation Research
|
September 16, 2006
Homocysteine and cardiovascular disease: is HDL the link?
Philip J Barter, Kerry-Anne Rye
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 24, 2008
Antiinflammatory actions of HDL: a new insight
Kerry-Anne Rye, Philip J Barter
The Journal of Clinical Endocrinology and Metabolism
|
May 17, 2019
HDL Cholesterol Level and Mortality Occurrence in the Elderly: Is the Good Cholesterol Always Good?
Raul D Santos, Philip J Barter
Circulation Research
|
January 4, 2014
Regulation of high-density lipoprotein metabolism
Kerry-Anne Rye, Philip J Barter
Page
of 17